BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 28771784)

  • 1. A qualitative study of decision-making on Phase III randomized clinical trial participation in paediatric oncology: Adolescents' and parents' perspectives and preferences.
    Ingersgaard MV; Tulstrup M; Schmiegelow K; Larsen HB
    J Adv Nurs; 2018 Jan; 74(1):110-118. PubMed ID: 28771784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parents' and Adolescents' Preferences for Intensified or Reduced Treatment in Randomized Lymphoblastic Leukemia Trials.
    Tulstrup M; Larsen HB; Castor A; Rossel P; Grell K; Heyman M; Abrahamsson J; Söderhäll S; Åsberg A; Jonsson OG; Vettenranta K; Frandsen TL; Albertsen BK; Schmiegelow K;
    Pediatr Blood Cancer; 2016 May; 63(5):865-71. PubMed ID: 26717887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol.
    Henriksen LT; Harila-Saari A; Ruud E; Abrahamsson J; Pruunsild K; Vaitkeviciene G; Jónsson ÓG; Schmiegelow K; Heyman M; Schrøder H; Albertsen BK;
    Pediatr Blood Cancer; 2015 Mar; 62(3):427-33. PubMed ID: 25418987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol.
    Raja RA; Schmiegelow K; Albertsen BK; Prunsild K; Zeller B; Vaitkeviciene G; Abrahamsson J; Heyman M; Taskinen M; Harila-Saari A; Kanerva J; Frandsen TL;
    Br J Haematol; 2014 Apr; 165(1):126-33. PubMed ID: 24428625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age.
    Rank CU; Wolthers BO; Grell K; Albertsen BK; Frandsen TL; Overgaard UM; Toft N; Nielsen OJ; Wehner PS; Harila-Saari A; Heyman MM; Malmros J; Abrahamsson J; Norén-Nyström U; Tomaszewska-Toporska B; Lund B; Jarvis KB; Quist-Paulsen P; Vaitkevičienė GE; Griškevičius L; Taskinen M; Wartiovaara-Kautto U; Lepik K; Punab M; Jónsson ÓG; Schmiegelow K
    J Clin Oncol; 2020 Jan; 38(2):145-154. PubMed ID: 31770057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study.
    Albertsen BK; Grell K; Abrahamsson J; Lund B; Vettenranta K; Jónsson ÓG; Frandsen TL; Wolthers BO; Heyman M; Schmiegelow K
    J Clin Oncol; 2019 Jul; 37(19):1638-1646. PubMed ID: 30978155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.
    Toksvang LN; De Pietri S; Nielsen SN; Nersting J; Albertsen BK; Wehner PS; Rosthøj S; Lähteenmäki PM; Nilsson D; Nystad TA; Grell K; Frandsen TL; Schmiegelow K
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28423235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
    Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
    Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged first-line PEG-asparaginase treatment in pediatric acute lymphoblastic leukemia in the NOPHO ALL2008 protocol-Pharmacokinetics and antibody formation.
    Tram Henriksen L; Gottschalk Højfeldt S; Schmiegelow K; Frandsen TL; Skov Wehner P; Schrøder H; Klug Albertsen B;
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28660740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrolling adolescents in asthma research: adolescent, parent, and physician influence in the decision-making process.
    Brody JL; Annett RD; Scherer DG; Turner C; Dalen J
    J Asthma; 2009 Jun; 46(5):492-7. PubMed ID: 19544171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision-making in childhood cancer: parents' and adolescents' views and perceptions.
    Robertson EG; Wakefield CE; Shaw J; Darlington AS; McGill BC; Cohn RJ; Fardell JE
    Support Care Cancer; 2019 Nov; 27(11):4331-4340. PubMed ID: 30880372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
    Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
    Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Children's participation in shared decision-making: children, adolescents, parents and healthcare professionals' perspectives and experiences.
    Coyne I; Amory A; Kiernan G; Gibson F
    Eur J Oncol Nurs; 2014 Jun; 18(3):273-80. PubMed ID: 24629505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).
    Dinndorf PA; Gootenberg J; Cohen MH; Keegan P; Pazdur R
    Oncologist; 2007 Aug; 12(8):991-8. PubMed ID: 17766659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parents' perspectives on user participation and shared decision-making in adolescents' inpatient mental healthcare.
    Bjønness S; Grønnestad T; Johannessen JO; Storm M
    Health Expect; 2022 Jun; 25(3):994-1003. PubMed ID: 35129846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer care in Romania: challenges and pitfalls of children's and adolescents' multifaceted involvement.
    Badarau DO; De Clercq E; Wangmo T; Dragomir M; Miron I; Kühne T; Elger BS
    J Med Ethics; 2016 Dec; 42(12):757-761. PubMed ID: 27697792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid asparagine depletion during pegylated asparaginase therapy in children with acute lymphoblastic leukaemia.
    Henriksen LT; Nersting J; Raja RA; Frandsen TL; Rosthøj S; Schrøder H; Albertsen BK;
    Br J Haematol; 2014 Jul; 166(2):213-20. PubMed ID: 24702187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surrendering control, or nothing to lose: Parents' preferences about participation in a randomised trial of childhood strabismus surgery.
    Buck D; Hogan V; Powell CJ; Sloper JJ; Speed C; Taylor RH; Tiffin P; Clarke MP;
    Clin Trials; 2015 Aug; 12(4):384-93. PubMed ID: 25805203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peg-asparaginase for acute lymphoblastic leukemia.
    Rytting M
    Expert Opin Biol Ther; 2010 May; 10(5):833-9. PubMed ID: 20345338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parental decision making regarding consent to randomization on Children's Oncology Group AALL0932.
    Parker K; Cottrell E; Stork L; Lindemulder S
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28907. PubMed ID: 33501773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.